Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2011
03/03/2011US20110053939 Novel aromatic nitro compounds
03/03/2011US20110053932 Protein Kinase Inhibitors and Methods for Using Thereof
03/03/2011US20110053931 Quinoline compounds and methods of use
03/03/2011US20110053925 Hydroxamate-Based Inhibitors of Deacetylases
03/03/2011US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
03/03/2011US20110053905 Compounds as tyrosine kinase modulators
03/03/2011US20110053897 Compounds and compositions as syk kinase inhibitors
03/03/2011US20110053893 Compounds and compositions as tlr activity modulators
03/03/2011US20110053887 Socs3 expression promoter, drug and food containing the same and method of promoting the expression of socs3
03/03/2011US20110053885 Pharmaceutical agent having long-lasting effect of treating arthritic disorders
03/03/2011US20110053877 Nimesulide and muscle relaxant combinations thereof
03/03/2011US20110053873 Hsp90 inhibitors
03/03/2011US20110053855 Ex vivo cell stimulation
03/03/2011US20110053841 N-terminal fgf variants having increased receptor selectivity and uses thereof
03/03/2011US20110053840 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides
03/03/2011US20110052737 Topical skin formulations comprising botanical extracts
03/03/2011US20110052729 Pharmaceutical or nutraceutical composition
03/03/2011US20110052711 Controlled release multidrug formulations for spinal cord injury
03/03/2011US20110052705 Cartilage composition and process for producing the cartilage composition
03/03/2011US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
03/03/2011US20110052670 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
03/03/2011US20110052660 Ceramic scaffolds for bone repair
03/03/2011US20110052643 Compounds for inflammation and immune-related uses
03/03/2011US20110052612 Spiropiperidine compound and medicinal use thereof
03/03/2011US20110052609 Magnetic transducers
03/03/2011US20110052604 Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors
03/03/2011US20110052597 Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof
03/03/2011US20110052596 Antibodies to il-17a
03/03/2011US20110052592 Compositions and Methods for Use for Antibodies Against Sclerostin
03/03/2011US20110052585 Compositions and methods for inhibiting interleukin pathways
03/03/2011US20110052573 14-3-3 ETA Antibodies and Uses Thereof for the Diagnosis and Treatment of Arthritis
03/03/2011US20110052562 Benzimidazoles and analogs as rho kinase inhibitors
03/03/2011US20110052561 Osteolysis treatment
03/03/2011US20110052538 Probiotic/non-probiotic combinations
03/03/2011US20110052535 Compositions for treating an inflammatory autoimmune condition
03/03/2011US20110052533 Compositions and Methods for Cartilage Repair
03/03/2011US20110052524 vertebroplasty method using an addition curable polysiloxane system
03/03/2011US20110052501 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
03/03/2011CA2770866A1 Cannabinoid receptor modulators
03/03/2011CA2770778A1 Pharmaceutical composition for preventing or treating rheumatoid arthritis containing rebamipide
03/03/2011CA2759815A1 Method of treating frailty
03/02/2011EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors
03/02/2011EP2289555A1 Method of treating frailty
03/02/2011EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells
03/02/2011EP2289549A2 Immunoconjugates for treating cancer
03/02/2011EP2289536A1 Use of bone morphogenetic proteins for healing and repair of connective tissue attachment
03/02/2011EP2289523A2 Regimens for intra-articular viscosupplementation
03/02/2011EP2289504A2 SIRT1 modulators for manipulating cell/organism lifespan/stress response
03/02/2011EP2289503A2 Treating muscle wasting with selective androgen receptor modulators
03/02/2011EP2288396A2 Stimulation of cartilage formation using reduced pressure treatment and chondrocytes
03/02/2011EP2288376A2 Methods of generating and using procollagen
03/02/2011EP2288258A1 Inhibition of neovascularization by cerium oxide nanoparticles
03/02/2011EP2066685B1 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists
03/02/2011EP1831174B1 Amide derivatives
03/02/2011EP1773332B1 Pharmaceutical composition for the treatment of bone fracture
03/02/2011EP1646656B1 Human antibody molecules for il-13
03/02/2011EP1638552B1 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer
03/02/2011EP1437969B1 Instruments for autologous transplantation
03/02/2011EP1417975B1 Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
03/02/2011EP1416880B1 Cartilage repair apparatus
03/02/2011EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
03/02/2011CN101983057A Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds
03/02/2011CN101982471A Technological process for extracting aucubin from fruits of eucommia ulmoides oliver
03/02/2011CN101982195A Medicine for treating rheumatoid arthritis pain and preparation method thereof
03/02/2011CN101982169A Novel external non-plaster patch
03/02/2011CN101590171B Chinese medicinal composition for treating acute ankle sprain
03/01/2011US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue
03/01/2011US7897644 Antiinflammatory agents; analgesics
03/01/2011US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists
03/01/2011US7897384 Chondrocyte therapeutic delivery system
03/01/2011US7897174 Formulation comprising bioactive agents and method of using same
03/01/2011CA2437240C Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
03/01/2011CA2348954C A pharmaceutical composition for treating immune diseases
02/2011
02/24/2011WO2011022539A2 Methods for administration of colchicine with grapefruit juice
02/24/2011WO2011022532A2 Methods for concomitant administration of colchicine and a second active agent
02/24/2011WO2011022449A1 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones
02/24/2011WO2011022394A2 Materials and methods for the development of an antigen-specific immune non-responsiveness state
02/24/2011WO2011022070A2 Perivascular stem cell composition for bone
02/24/2011WO2011021833A2 Composition for preventing or treating inflammation
02/24/2011WO2011021712A1 Substratum for supplying cells/tissues, cell/tissue supply material and process for production thereof, method for regeneration of tissues, and process for production of porous material
02/24/2011WO2011021678A1 Fused heterocyclic compound
02/24/2011WO2010123930A3 Chemosensory receptor ligand-based therapies
02/24/2011WO2010111525A3 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
02/24/2011US20110046686 3-dimensional silk hydroxyapatite compositions
02/24/2011US20110046402 Novel method and intermediates for preparing 19-norsteroid compounds
02/24/2011US20110046237 Compounds with activity at estrogen receptors
02/24/2011US20110046235 Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee
02/24/2011US20110046228 Methods for administration of colchicine with grapefruit juice
02/24/2011US20110046223 Treatment of neurofibromatosis
02/24/2011US20110046222 Fatty acid amides and uses thereof
02/24/2011US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors
02/24/2011US20110046179 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
02/24/2011US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists
02/24/2011US20110046151 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
02/24/2011US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors
02/24/2011US20110046131 Purines as pkc-theta inhibitors
02/24/2011US20110046122 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
02/24/2011US20110046113 Amine compound and use thereof
02/24/2011US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
02/24/2011US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors